Hjem › Post-COVID-tilstander (lang-COVID) › Virginia
Kliniske studier for Post-COVID-tilstander (lang-COVID) i Virginia
6 studier for Post-COVID-tilstander (lang-COVID) søker deltakere på steder i Virginia.
Offisiell studietekst (engelsk)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Velocity Clinical Research - Hampton ( Site 3744), Hampton
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Charlottesville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Velocity Clinical Research, Suffolk, Suffolk
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Charlottesville
- GSK Investigational Site, Newport News
RekruttererFase 1
Alder 65 til 85 · Alle kjønn · Oppdatert 30. jun. 2026 · NCT07464314Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- VCU Health System, Richmond
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT03808922A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- Richard Bennett - Clinical Research Partners, Richmond
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
6 Months · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06585241Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.